CALVIN TERRELONGE: Open Payments
NPI 1124236187 · BETHLEHEM, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 25 payments from 12 companies in 2025. Trend: 2023 $888 · 2024 $880 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $195 |
| Abbott Laboratories | 3 | $69 |
| Dexcom, Inc. | 2 | $45 |
| Exact Sciences Corporation | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Amgen Inc. | 2 | $42 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: Ozempic, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, Rybelsus, OTEZLA, SAPIEN 3 Ultra RESILIA, VOQUEZNA, Wegovy.
Industry payments across GA — which companies pay providers there.
